| Filed On | Filing |
|---|---|
| 26 Oct 2026 |
Form 4: Zohar Nadav, Director
Received 13,512 shares as a grant or award |
| 26 Oct 2026 |
Form 4: Reis David M, Director
Received 23,768 shares as a grant or award |
| 26 Oct 2026 |
Form 4: Makov Efrat, Director
Received 13,512 shares as a grant or award |
| 26 Oct 2026 |
Form 4: Kesten Raphael, Director
Received 13,512 shares as a grant or award |
| 26 Oct 2026 |
Form 4: Levy Steven D, Director
Received 13,512 shares as a grant or award |
| 22 Oct 2026 | 6-K |
| 15 Sep 2026 | 6-K |
| 10 Sep 2026 | 6-K |
| 09 Sep 2026 | 6-K |
| 31 Aug 2026 |
Form 4: Grossman Boaz, Senior Vice President R&D
Sold 4,000 shares ($31.2K) |
| 31 Aug 2026 | 144 |
| 26 Aug 2026 | SCHEDULE 13D/A |
| 24 Aug 2026 |
Form 4: Grossman Boaz, Senior Vice President R&D
Sold 6,000 shares ($44.7K) |
| 24 Aug 2026 | 144 |
| 19 Aug 2026 |
Form 4: Groner Gili, Chief Human Resources Officer
Sold 26,666 shares ($210K) |
| 14 Aug 2026 | 144 |
| 12 Aug 2026 | 6-K |
| 10 Aug 2026 |
Form 4: Harari Eyal David, Chief Executive Officer
Sold 29,111 shares ($222K) |
| 07 Aug 2026 | 144 |
| 04 Aug 2026 |
Form 4: Charash Inbar, General Counsel
Sold 556 shares ($4.34K) |
Loading...